サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1572032

グルコースバイオセンサーの世界市場

Glucose Biosensors

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.26円
グルコースバイオセンサーの世界市場
出版日: 2024年10月18日
発行: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

グルコースバイオセンサーの世界市場は2030年までに41億米ドルに達する見込み

2023年に36億米ドルと推定されるグルコースバイオセンサーの世界市場は、分析期間2023-2030年にCAGR 2.1％で成長し、2030年には41億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである病院最終用途は、CAGR 1.8％を記録し、分析期間終了までに15億米ドルに達すると予測されます。在宅ケア診断最終用途分野の成長率は、分析期間中CAGR 2.5%と推定されます。

米国市場は9億6,030万米ドル、中国はCAGR 3.1％で成長予測

米国のグルコースバイオセンサー市場は、2023年に9億6,030万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに7億6,560万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは3.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5%と1.9%と予測されています。欧州では、ドイツがCAGR 1.8%で成長すると予測されています。

世界のグルコースバイオセンサー市場- 主要動向と促進要因のまとめ

グルコースバイオセンサーはどのように糖尿病管理を強化しているのか？

グルコースバイオセンサーは糖尿病管理における重要なツールであり、患者に血糖値のリアルタイムモニタリングを提供します。グルコースメーターや持続グルコースモニタリング（CGM）機器に不可欠なこれらのセンサーは、酵素反応や電気化学的検出法を用いて血液中のグルコース濃度を測定します。24時間体制で追跡可能な持続グルコース・モニタリング・システムは、患者にインスリン投与、食事、活動に関する十分な情報に基づいた意思決定を行うためのより多くのデータを提供することで、糖尿病管理を大幅に改善しました。世界の糖尿病有病率の上昇に伴い、正確で信頼性が高く、ユーザーフレンドリーなグルコースバイオセンサーの需要は増加傾向にあり、患者が病状をよりよくコントロールできるよう支援しています。

グルコースバイオセンサーの主要セグメントとアプリケーションは？

グルコースバイオセンサー市場は、電気化学バイオセンサー、光学バイオセンサー、酵素バイオセンサーなどの技術別にセグメント化されています。電気化学バイオセンサーは、酵素反応によって生成される電気信号を通してグルコース濃度を測定するもので、その精度、手頃な価格、CGMデバイスやグルコースメーターでの普及により、市場を独占しています。光に基づく検出方法を使用する光学式バイオセンサーも、特に非侵襲的モニタリングシステムで人気を集めています。アプリケーションの面では、グルコースバイオセンサーは主に自己血糖測定（SMBG）システムや持続グルコースモニタリング装置に使用されています。病院、クリニック、在宅医療が主なエンドユーザーです。北米は糖尿病の有病率が高く、医療インフラが発達しているため市場をリードしているが、アジア太平洋は糖尿病罹患率の上昇と医療へのアクセスの向上により急成長を遂げています。

技術の進歩はグルコースバイオセンサーにどのような影響を与えているか？

技術革新は、特に非侵襲的モニタリング、センサーの精度、デジタルヘルスプラットフォームとの統合の分野で、グルコースバイオセンサーの改善を促進しています。ウェアラブルセンサーを通じてリアルタイムデータを提供する持続グルコースモニタリング（CGM）システムは、頻繁に指を刺す検査の必要性を減らすことで、糖尿病管理を一変させました。センサーの小型化、生体適合素材、ワイヤレス接続の進歩により、これらのデバイスは患者にとってより快適で便利なものとなっています。グルコースバイオセンサーをモバイルアプリやクラウドプラットフォームと統合することで、患者や医療提供者は動向を追跡し、データに基づいた意思決定を行うことができます。さらに、光学センサーや経皮センサーなど、非侵襲的なグルコースモニタリング方法の調査は、糖尿病治療の将来にとって有望です。

グルコースバイオセンサー市場の成長を促進する要因は？

グルコースバイオセンサー市場の成長は、世界の糖尿病有病率の上昇や、継続的なリアルタイムのグルコースモニタリングソリューションに対する需要の増加など、いくつかの要因によって牽引されています。センサーの精度の向上、小型化、非侵襲的モニタリング技術など、バイオセンサー技術の進歩は、患者体験を向上させ、臨床と家庭の両方の環境でグルコースバイオセンサーの使用を拡大しています。糖尿病管理の改善を目的とした政府の取り組みやヘルスケア政策が、高度なグルコースモニタリングデバイスの採用をさらに後押ししています。また、グルコースバイオセンサーとデジタルヘルスプラットフォームの統合が進み、患者と医療従事者のコミュニケーションやデータ分析が向上していることも、市場の成長を後押ししています。

調査対象企業の例（全42件）

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • AgaMatrix Inc.
  • Bayer
  • Biacore
  • BioSense Medical Devices, LLC
  • Biosensors International Pte. Ltd.
  • LifeScan, Inc.
  • LifeSensors, Inc.
  • Medtronic, Inc.
  • Nova Biomedical
  • Pharmaco-Kinesis Corporation
  • Pinnacle Medical Solutions, Inc.
  • Roche Diagnostics
  • Sanofi S.A.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP21894

Global Glucose Biosensors Market to Reach US$4.1 Billion by 2030

The global market for Glucose Biosensors estimated at US$3.6 Billion in the year 2023, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 2.1% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Homecare Diagnostics End-Use segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$960.3 Million While China is Forecast to Grow at 3.1% CAGR

The Glucose Biosensors market in the U.S. is estimated at US$960.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$765.6 Million by the year 2030 trailing a CAGR of 3.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Glucose Biosensors Market - Key Trends and Drivers Summarized

How Are Glucose Biosensors Enhancing Diabetes Management?

Glucose biosensors are critical tools in the management of diabetes, providing real-time monitoring of blood glucose levels for patients. These sensors, which are integral to glucose meters and continuous glucose monitoring (CGM) devices, measure the concentration of glucose in the blood using enzymatic reactions and electrochemical detection methods. Continuous glucose monitoring systems, which offer around-the-clock tracking, have significantly improved diabetes management by providing patients with more data to make informed decisions about their insulin dosing, diet, and activity. With the rising prevalence of diabetes worldwide, the demand for accurate, reliable, and user-friendly glucose biosensors is on the rise, helping patients maintain better control over their condition.

What Are the Key Segments and Applications of Glucose Biosensors?

The glucose biosensors market is segmented by technology, including electrochemical, optical, and enzymatic biosensors. Electrochemical biosensors, which measure glucose concentration through electrical signals generated by enzymatic reactions, dominate the market due to their accuracy, affordability, and widespread use in CGM devices and glucose meters. Optical biosensors, which use light-based detection methods, are also gaining traction, particularly for non-invasive monitoring systems. In terms of application, glucose biosensors are primarily used in self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring devices. Hospitals, clinics, and home healthcare settings represent the primary end-users. North America leads the market due to the high prevalence of diabetes and advanced healthcare infrastructure, while Asia-Pacific is experiencing rapid growth as diabetes rates rise and access to healthcare improves.

How Are Technological Advancements Impacting Glucose Biosensors?

Technological innovations are driving improvements in glucose biosensors, particularly in the areas of non-invasive monitoring, sensor accuracy, and integration with digital health platforms. Continuous glucose monitoring (CGM) systems, which provide real-time data through wearable sensors, have transformed diabetes management by reducing the need for frequent finger-prick tests. Advances in sensor miniaturization, biocompatible materials, and wireless connectivity are making these devices more comfortable and convenient for patients. The integration of glucose biosensors with mobile apps and cloud platforms is enabling patients and healthcare providers to track trends and make data-driven decisions. Additionally, research into non-invasive glucose monitoring methods, such as optical and transdermal sensors, holds promise for the future of diabetes care.

What Factors Are Driving the Growth in the Glucose Biosensors Market?

The growth in the glucose biosensors market is driven by several factors, including the rising global prevalence of diabetes and the increasing demand for continuous, real-time glucose monitoring solutions. Advances in biosensor technology, including improvements in sensor accuracy, miniaturization, and non-invasive monitoring techniques, are enhancing the patient experience and expanding the use of glucose biosensors in both clinical and home settings. Government initiatives and healthcare policies aimed at improving diabetes management are further supporting the adoption of advanced glucose monitoring devices. The growing integration of glucose biosensors with digital health platforms, enabling better patient-provider communication and data analysis, is also fueling market growth.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • AgaMatrix Inc.
  • Bayer
  • Biacore
  • BioSense Medical Devices, LLC
  • Biosensors International Pte. Ltd.
  • LifeScan, Inc.
  • LifeSensors, Inc.
  • Medtronic, Inc.
  • Nova Biomedical
  • Pharmaco-Kinesis Corporation
  • Pinnacle Medical Solutions, Inc.
  • Roche Diagnostics
  • Sanofi S.A.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Glucose Biosensors - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Globally Propels Demand for Glucose Biosensors
    • Technological Innovations in Continuous Glucose Monitoring (CGM) Devices Strengthen Market Growth
    • Increasing Adoption of Wearable Glucose Biosensors Drives Market Expansion
    • Growing Focus on Non-Invasive Glucose Monitoring Technologies Creates Opportunities
    • Rising Demand for Portable and Convenient Glucose Monitoring Devices Expands Addressable Market
    • Advancements in Sensor Accuracy and Reliability Propel Adoption of Glucose Biosensors
    • Increasing Integration of Biosensors with Mobile Apps and Cloud Platforms Boosts Demand
    • Rising Adoption of Glucose Biosensors in Personalized Medicine Strengthens Business Case
    • Growing Preference for Continuous Glucose Monitoring over Traditional Testing Methods Drives Growth
    • Technological Developments in Miniaturized and Implantable Biosensors Spur Innovation
    • Rising Demand for Real-Time Monitoring Solutions in Healthcare Expands Market for Biosensors
    • Growing Healthcare Expenditure and Insurance Coverage for Diabetes Management Support Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Glucose Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Homecare Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Homecare Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Homecare Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Glucose Biosensors Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Glucose Biosensors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Glucose Biosensors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Glucose Biosensors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Glucose Biosensors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION